Non-Hodgkin Lymphoma

Filter By:
Download from iTunes: https://itun... When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapi...
by:mdanderson | 366 views
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 915 views
Download from iTunes: https://itun... Diffuse large b-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma (NHL). DLBCL is fast growing and can develop in lymph nodes, gastrointestina​l tract, testicles, thyroid, skin, brain, bone or breast. Jason Westin, M...
by:mdanderson | 2402 views
Download from iTunes: https://itun... Non-Hodgkin's lymphoma is the seventh most common cancer in men and women in the United States and often misdiagnosed by primary care doctors. Symptoms may include headaches, confusion, nausea and fatigue. Jason Westin, M.D., assistant pro...
by:mdanderson | 2272 views
Non-Hodgkin lymphoma is currently incurable, but there have been recent discoveries that may change that. New oral medicines are showing great promise in reducing tumors for patients with certain subtypes of the disease. These discoveries are leading the way to find more therapies that target specif...
by:patientpower | 1926 views
Cristina Rodriguez is a 31-year-old non-Hodgkin's lymphoma fighter. In this video, she discusses her symptoms and diagnosis with stage four non-Hodgkin's lymphoma. READ HER STORY- http://bit.l...
by:mdanderson | 1103 views
Dr. Ajay Gopal, Director of Hematologic Malignancies at the Seattle Cancer Care Alliance, explains the results from a recent, large study using radioimmunother​apy prior to transplant for Non-Hodkin's Lymphoma patients. As the lead investigator on this trial, Dr. Gopal affirms that the results provid...
by:patientpower | 1807 views
Medical oncologist Alexander Lesokhin discusses a phase I clinical trial assessing anti-PD-1 immunotherapy in patients with relapsed or refractory hematologic cancers [http://www.m...)]. These drugs are designed to boost the body's immune system against cancer by target...
by:mskcc | 2215 views
Mantle cell lymphoma (MCL) is a rare form of blood cancer belonging to the disease group classified as non-Hodgkin's lymphoma. Only 3-6% of all non-Hodgkin’s lymphoma cases in the United States are MCL. Michael Wang, M.D., associate professor, and Jorge Romaguera, M.D., professor, both in Lymphoma/Myelom​a at MD Anderson Cancer Center, discuss this ...
by:mdanderson | 1455 views
Non-Hodgkin's Lymphoma (NHL) Expert Video Viewpoints–Thou​ght Leader Perspectives on the Latest Hematology Advances with Andre Goy, MD Hackensack University Medical Center IMEReporting Live is a series of CME/CE-certifie​d videos that highlight emerging and evolving data reported at ASH 2011 on the treatment of multiple myeloma, lymphomas, and le...
by:imeronline | 3450 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)